These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 10190549)
1. Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Lettieri T; Marra G; Aquilina G; Bignami M; Crompton NE; Palombo F; Jiricny J Carcinogenesis; 1999 Mar; 20(3):373-82. PubMed ID: 10190549 [TBL] [Abstract][Full Text] [Related]
2. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Umar A; Koi M; Risinger JI; Glaab WE; Tindall KR; Kolodner RD; Boland CR; Barrett JC; Kunkel TA Cancer Res; 1997 Sep; 57(18):3949-55. PubMed ID: 9307278 [TBL] [Abstract][Full Text] [Related]
3. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Ohmiya N; Matsumoto S; Yamamoto H; Baranovskaya S; Malkhosyan SR; Perucho M Gene; 2001 Jul; 272(1-2):301-13. PubMed ID: 11470537 [TBL] [Abstract][Full Text] [Related]
4. Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor. Glaab WE; Risinger JI; Umar A; Kunkel TA; Barrett JC; Tindall KR J Biol Chem; 1998 Oct; 273(41):26662-9. PubMed ID: 9756907 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer. Liu L; Schwartz S; Davis BM; Gerson SL Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916 [TBL] [Abstract][Full Text] [Related]
6. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Levati L; Marra G; Lettieri T; D'Atri S; Vernole P; Tentori L; Lacal PM; Pagani E; Bonmassar E; Jiricny J; Graziani G Genes Chromosomes Cancer; 1998 Oct; 23(2):159-66. PubMed ID: 9739019 [TBL] [Abstract][Full Text] [Related]
7. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Liu L; Markowitz S; Gerson SL Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088 [TBL] [Abstract][Full Text] [Related]
8. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Koi M; Umar A; Chauhan DP; Cherian SP; Carethers JM; Kunkel TA; Boland CR Cancer Res; 1994 Aug; 54(16):4308-12. PubMed ID: 8044777 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by overexpression of hMSH2 or hMLH1. Zhang H; Richards B; Wilson T; Lloyd M; Cranston A; Thorburn A; Fishel R; Meuth M Cancer Res; 1999 Jul; 59(13):3021-7. PubMed ID: 10397236 [TBL] [Abstract][Full Text] [Related]
10. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Parc YR; Halling KC; Wang L; Christensen ER; Cunningham JM; French AJ; Burgart LJ; Price-Troska TL; Roche PC; Thibodeau SN Cancer Res; 2000 Apr; 60(8):2225-31. PubMed ID: 10786688 [TBL] [Abstract][Full Text] [Related]
12. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550 [TBL] [Abstract][Full Text] [Related]
13. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants. Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806 [TBL] [Abstract][Full Text] [Related]
14. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548 [TBL] [Abstract][Full Text] [Related]
15. Expression of the hMSH6 mismatch-repair protein in colon cancer and HeLa cells. Klingler H; Hemmerle C; Bannwart F; Haider R; Cattaruzza MS; Marra G Swiss Med Wkly; 2002 Feb; 132(5-6):57-63. PubMed ID: 11971198 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183 [TBL] [Abstract][Full Text] [Related]
17. Functional overlap in mismatch repair by human MSH3 and MSH6. Umar A; Risinger JI; Glaab WE; Tindall KR; Barrett JC; Kunkel TA Genetics; 1998 Apr; 148(4):1637-46. PubMed ID: 9560383 [TBL] [Abstract][Full Text] [Related]
18. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents. Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455 [TBL] [Abstract][Full Text] [Related]
19. Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex. Hou Y; Gao F; Wang Q; Zhao J; Flagg T; Zhang Y; Deng X J Biol Chem; 2007 Mar; 282(12):9279-87. PubMed ID: 17259174 [TBL] [Abstract][Full Text] [Related]
20. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Baranovskaya S; Soto JL; Perucho M; Malkhosyan SR Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15107-12. PubMed ID: 11742074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]